These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 14429233)

  • 21. [On the relation between diphtheric allergy and antitoxin production].
    OMAE S
    Nihon Densenbyo Gakkai Zasshi; 1962 May; 36():43-57. PubMed ID: 14481978
    [No Abstract]   [Full Text] [Related]  

  • 22. [Complement activation and biological activities].
    Inoue K
    Nihon Saikingaku Zasshi; 1976 Jul; 31(4):535-55. PubMed ID: 988219
    [No Abstract]   [Full Text] [Related]  

  • 23. [Protection of the guinea pig against fatal anaphylactic shock by anaphylatoxin and its mechanism].
    HALPERN BN; LIACOPOULOS P
    C R Seances Soc Biol Fil; 1956 May; 150(1):108-12. PubMed ID: 13330298
    [No Abstract]   [Full Text] [Related]  

  • 24. [Mechanism of protection in guinea pigs against a mortal anaphylactic shock with anaphylatoxin].
    BRIOT M; HALPERN BN; LIACOPOULOS P
    Sem Hop; 1956 Sep; 32(56):2858-60. PubMed ID: 13380458
    [No Abstract]   [Full Text] [Related]  

  • 25. Studies on the mechanism of hypersensitivity phenomena. II. The participation of complement in passive cutaneous anaphylaxis of the albino rat.
    OSLER AG; HAWRISIAK MM; OVARY Z; SIQUEIRA M; BIER OG
    J Exp Med; 1957 Dec; 106(6):811-34. PubMed ID: 13481246
    [TBL] [Abstract][Full Text] [Related]  

  • 26. VIBRIO FETUS TOXIN. I. HYPERSENSITIVITY AND ABORTIFACIENT ACTION.
    OSBORNE JC; SMIBERT RM
    Cornell Vet; 1964 Oct; 54():561-72. PubMed ID: 14234060
    [No Abstract]   [Full Text] [Related]  

  • 27. Anaphylatoxin--the rebirth of an old concept.
    Weil AJ
    Ann Allergy; 1968 Apr; 26(4):211-2. PubMed ID: 4868733
    [No Abstract]   [Full Text] [Related]  

  • 28. [Further studies on the formation and nature of anaphylatoxin].
    GIERTZ H; HAHN F
    Int Arch Allergy Appl Immunol; 1961; 19():94-111. PubMed ID: 13705172
    [No Abstract]   [Full Text] [Related]  

  • 29. [Passive heterologous local cutaneous anaphylaxis in the guinea pig].
    OVARY Z
    Boll Soc Ital Biol Sper; 1951; 27(1-2):102-4. PubMed ID: 14848310
    [No Abstract]   [Full Text] [Related]  

  • 30. The mechanism and nature of the complement reaction as related to toxin-antitoxin dissociation.
    STEWART SE; VIVINO AE
    J Bacteriol; 1946 May; 51():626. PubMed ID: 21064742
    [No Abstract]   [Full Text] [Related]  

  • 31. Studies on the immunologic mechanism of anaphylaxis. I. Antibody-hapten interactions studied by passive cutaneous anaphylaxis in the guinea pig.
    OVARY Z; KARUSH F
    J Immunol; 1960 Apr; 84():409-15. PubMed ID: 14429492
    [No Abstract]   [Full Text] [Related]  

  • 32. [On Bombyx mori toxins and their effects on the human organism].
    BOCHAROV AP; SOLOV'EVA AF
    Gig Tr Prof Zabol; 1961 Nov; 5():47-9. PubMed ID: 13870352
    [No Abstract]   [Full Text] [Related]  

  • 33. Immunologic mechanism of anaphylaxis. III. Inhibition phenomenon in passive cutaneous anaphylaxis in the mouse.
    GARDNER RC; OVARY Z
    Proc Soc Exp Biol Med; 1960 Nov; 105():342-4. PubMed ID: 13703623
    [No Abstract]   [Full Text] [Related]  

  • 34. IMMUNOLOGIC BASIS OF NEPHRITIS.
    PETERS JH
    Biochem Clin; 1963; 2():137-59. PubMed ID: 14095791
    [No Abstract]   [Full Text] [Related]  

  • 35. BACTERIAL ALLERGY AND INFECTION.
    MILLMAN M
    Ann Allergy; 1964 Jul; 22():369-73. PubMed ID: 14180064
    [No Abstract]   [Full Text] [Related]  

  • 36. The relation between molecular weight of antigen and ability to elicit passive cutaneous anaphylaxis.
    LESKOWITZ S; OVARY Z
    Immunology; 1962 Jan; 5(1):1-10. PubMed ID: 14464304
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Granulopexy and increase of permeability of the small vessels. IV. The increase of permeability of the small vessels during passive local cutaneous anaphylaxis of the guinea pig].
    OVARY Z
    Boll Soc Ital Biol Sper; 1950 Mar; 26(3):330-2. PubMed ID: 15434184
    [No Abstract]   [Full Text] [Related]  

  • 38. Factors and conditions essential for activation of the fifth component of complement and release of anaphylatoxin (C5a).
    Vogt W; Schmidt G; von Buttlar B
    Monogr Allergy; 1977; 12():86-9. PubMed ID: 335222
    [No Abstract]   [Full Text] [Related]  

  • 39. Proceedings: Effect of the complement-derived peptides C3a and C5a (anaphylatoxin) on platelets of different species, in vitro.
    Grossklaus C; Damerau B; Vogt W
    Naunyn Schmiedebergs Arch Pharmacol; 1975; 287 Suppl():R59. PubMed ID: 1143463
    [No Abstract]   [Full Text] [Related]  

  • 40. [VIRULENCE OF MYCOBACTERIA, IMMUNITY AND ALLERGY OF TUBERCULOSIS].
    YAMAGUCHI H
    Iryo; 1964 Oct; 18():677-94. PubMed ID: 14229942
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.